Tag: Phase I Trial

Aquestive AQST-108 Epinephrine Film

Sublingual Emergency Epinephrine Takes Another Step Forward in Phase 1 Study

Aquestive's postage-stamp-sized film is designed to dissolve under the tongue to provide epinephrine.
Harmony Study

Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...

The study is still seeking participants 4-55 years of age.
Aquestive's Subingual Epinephrine

Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine

Company updates the public on status of their candidate drug administered under the tongue.
AQST-108 Phase 1

Emergency Epinephrine Film Begins Phase 1 Clinical Trials

First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Researchers

Phase I Trial for New Peanut Allergy Immunotherapy Results in No...

Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
Poop Pills by OpenBiome

Can Fecal Transplant Cure Peanut Allergy? Phase I Trial Underway

Can transplanting the microbiota of a healthy person to that of an allergic individual prevent allergic reactions?
Nasal Spray

Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins

Could lead the way to approval of a less anxiety provoking method of epinephrine administration.
Researchers

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.